<DOC>
	<DOC>NCT01129531</DOC>
	<brief_summary>This study will evaluate the safety and efficacy of AGN-214868 in patients with postherpetic neuralgia (PHN) - nerve pain.</brief_summary>
	<brief_title>A Study of the Safety and Efficacy of AGN-214868 in Patients With Postherpetic Neuralgia</brief_title>
	<detailed_description />
	<mesh_term>Neuralgia</mesh_term>
	<mesh_term>Neuralgia, Postherpetic</mesh_term>
	<criteria>Persistent postherpetic neuralgia (PHN) with nerve pain present for at least 9 months after onset of herpes zoster skin rash Female patients with reproductive potential Active herpes zoster skin rash Current or anticipated treatment with acupuncture, TNS, or steroids Current or anticipated use of topical analgesic agents with PHN Treatment with botulinum toxin therapy of any serotype within the prior 12 weeks</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2013</verification_date>
</DOC>